Clinical Trial

Hong Kong Diabesity Register & 3-Year Trial on Integrated Care for Chinese With Diabesity

Recruiting
View on ClinicalTrials.gov →
Summary
People with diabetes and obesity (diabesity) are difficult to treat with many unmet needs requiring personalized treatment regimens, intensive counselling and emotional support. Here, we propose to conduct a pragmatic trial including 2 parts: (1) establishment of a register for Hong Kong Chinese with diabesity and through this register, identify participants consecutively to enter (2) a 3-year randomized clinical trial to assess the effects of multicomponent integrated care program supported by a team of endocrinologist, dietitian, psychologist and research assistant with elements including medical therapy, cognitive behavioural therapy, e-care, artificial intelligence chatbot, biofeedback, peer support to improve the physical and mental health in people with diabesity, with weight reduction as primary outcome. Other outcomes include cardiometabolic risk factors, diabetes distress, lifestyles and sleep hygiene.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-06-25; most recent amendment 2026-03-01.
Status change: Not Yet Recruiting → Recruiting 2026-03-01
Trial Details
NCT Number NCT07039279
Lead Sponsor Chinese University of Hong Kong
Conditions Diabesity
Enrollment 200 participants
Start Date 2025-10-22
Primary Completion 2030-10-31 (estimated)
Study Completion 2030-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-03-03